Showing results (291-300 of 25,160) with videos related to

Sort By:
Pageof 2,516
Oncotarget|June 4, 2015
RhoE is required for contact inhibition and negatively regulates tumor initiation and progressionMarta Hernández-Sánchez, Enric Poch, Rosa M Guasch, et al.
Oncotarget|June 4, 2015
Bruton's tyrosine kinase (Btk) inhibitor ibrutinib suppresses stem-like traits in ovarian cancerMuhammad Ary Zucha, Alexander T H Wu, Wei-Hwa Lee, et al.
Oncotarget|June 4, 2015
Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cellsNitu Bansal, Prasun J Mishra, Mark Stein, et al.
Oncotarget|June 4, 2015
Down regulation of Akirin-2 increases chemosensitivity in human glioblastomas more efficiently than Twist-1Sebastian Krossa, Anne Dorothée Schmitt, Kirsten Hattermann, et al.
Oncotarget|June 4, 2015
Functional role of DNA mismatch repair gene PMS2 in prostate cancer cellsShinichiro Fukuhara, Inik Chang, Yozo Mitsui, et al.
Oncotarget|June 4, 2015
MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasisHaibing Xiao, Jin Zeng, Heng Li, et al.
Oncotarget|June 4, 2015
IPP51, a chalcone acting as a microtubule inhibitor with in vivo antitumor activity against bladder carcinomaVéronique Martel-Frachet, Michelle Keramidas, Alessandra Nurisso, et al.
Oncotarget|June 6, 2015
The peroxisome proliferator activated receptor gamma agonist pioglitazone increases functional expression of the glutamate transporter excitatory amino acid transporter 2 (EAAT2) in human glioblastoma cellsJared Ching, Stephanie Amiridis, Stanley S Stylli, et al.
Oncotarget|June 6, 2015
Identification of TAX2 peptide as a new unpredicted anti-cancer agentAlbin Jeanne, Emilie Sick, Jérôme Devy, et al.
Oncotarget|June 9, 2015
Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanismStefano J Mandriota, Linda J Valentijn, Laurence Lesne, et al.
Pageof 2,516